Haem - Malignant Conditions Flashcards

1
Q

ALL Hx

A
Child – typically 2-5 yrs old
Hepatosplenomegaly 
Bone pain / limp
Fevers 
CNS symptoms
Testicular swelling (rare but specific)§

Adults – similar to AML, lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ALL - Blood Tests

A

Usually present with thrombocytopenia and anaemia

High white cell count

Some analysers will indicate presence of blasts but sometimes these will be flagged as lymphocytes.

Circulating blasts are not normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ALL - Blood Film

A

High nucleus – cytoplasm ratio

It is not possible to tell ALL from AML on blood film most of the time!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ALL- Diagnosis

A

Diagnosis usually relies on Bone Marrow & Flow Cytometry

Typical features:
TdT +
CD19 / CD22 = B cells (more common)
CD 2 / CD 3 / CD 4/8 = T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALL - Genetics (Paeds)

A

ETV6-RUNX1 fusion gene & hyperdiploidy (extra chromosomes) are most common abnormalities

Both have a favourable prognosis

MLL gene mutations (now renamed KMT2A) have bad prognosis but are rare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALL- Genetics (Adults)

A

BCR-ABL1 t(9;22) associated with 20-30% of ALL in adults

This is the genetic mutation which also causes CML (covered later)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ALL - Rx

A

Chemotherapy:

Remission induction: Chemo agents often given with steroids

Consolidation: High dose multi drug chemotherapy
CNS treatment

Maintenance: 2 years in girls and adults, 3 years in boys –> remission

Consider allo-Stem Cell Transplant

Also use imatinib/other TKI for BCR-ABL1

Supportive: Blood products, ABx, Allopurinol, fluid, electrolytes – to prevent tumour lysis syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AML - Hx

A

Incidence increases with age
Might have had pre-existing myelodysplastic syndrome (MDS)
Symptoms of cytopenias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

AML - Blood Tests

A

Anaemia – due to bone marrow suppression

Thrombocytopenia – due to bone marrow suppression

Leukocytosis – high numbers of circulating white cells

Neutropenia – lack of mature white cells due to excess of blasts

High number of circulating blasts (not always flagged by analysers)

Normal INR – normal for AML
Abnormal INR (increased) – possible DIC due to acute promyelocytic leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AML - Blood Film

A

A single Auer rod is enough to diagnose AML* (or MDS)

But sometimes there are lots… “Faggot cells”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

AML - Dx

A

If no Auer rods present, flow cytometry needed to diagnose

Typical expression pattern: MPO – most specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

APML - Rx

A

T(15;17) Acute Promyelocytic Leukaemia
Presents with DIC. Good prognosis
All-Trans Retinoic Acid (ATRA) –> Forces cells to differentiate, stops proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AML- Rx

A

Similar to ALL (i.e. various combos of chemo/consider SC allo-transplant) but no CNS prophylaxis/maintenance therapy needed

Possibility of targeted agents in the future.

Poor prognosis, worse with increasing age - particularly in elderly who won’t tolerate stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Essential Thrombocytopenia (an MPN)

A

Proliferation of megakaryocytic/thrombocytes

Platelet Count >450 consistently
JAK2 mutation in 55%
No evidence of other cause

Treatment:
Aspirin to reduce stroke risk
Hydroxycarbamide to lower count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of thrombocytosis

A
Acute infection
Chronic inflammation 
Malignancy (5-10%)
Essential thrombocythaemia
Polycythaemia rubra vera
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Polycythaemia Vera

A

Proliferation of Erythrocytes

Haematocrit >0.52 / 0.48 (M / F)
Often thrombocytosis as well
High risk of thrombotic events e.g. MI, Stroke, Budd-Chiari

JAK2 mutation in 95%

Treatment:
Aspirin to reduce stroke risk
Venesection (taking blood to lower haematocrit)
Hydroxycarbamide to lower count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Causes of polycythaemia

A

Primary:
Polycythaemia rubra vera

Secondary:
Altitude
Chronic hypoxia: e.g. severe COPD, cyanotic heart disease
Erythropoietin-secreting renal cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Myelofibrosis

A

Clonal proliferation of stem cells in the bone marrow –> cytokine release and fibrosis of the bone marrow –> reduced production of all cell lineages

Features:
JAK2 mutation present in 50%
Pancytopenia
Splenomegaly (can be massive splenomegaly)
“dry tap” on bone marrow aspiration 
“tear drop poikilocytes” on blood film

Treatment:
Stem cell transplant likely only cure
Ruloxitinib - JAK inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CML - Hx and Ex

CML classified as a MPN

A

Typically onset age 35-55 in EMQs
LUQ pain - Splenomegaly
Mostly asymptomatic if diagnosed in chronic phase
May have lethargy, fatigue, fever, night sweats
May present with symptoms of acute leukaemia if in accelerated / blast phase (~10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CML - Blood Tests

A

In chronic phase – unlikely significantly anaemic (but can be)

In chronic phase – unlikely thrombocytopenia. 50% have elevated platelet count

Leukocytosis
Neutrophilia
May be elevated basophil count

Monocyte count should be low (high monocyte count would indicated CMML)

May be precursor cells flagged on blood differential e.g. promyleocytes, myleocytes (left shift)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Leukocytosis

A

Acute bacterial infection - Usually a high neutrophil : lymphocyte ratio

Acute viral infection - Usually a low neutrophil : lymphocyte ratio

Fungal / parasitic infection - Usually a high eosinophil count

Monocytosis - Unusual but seen in: TB, endocarditis, inflammatory conditions

In severe acute infections, there may be some precursor cells (myelocytes, metamyelocytes)

Elevated basophil AND eosinophil counts are concerning for malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CML - Blood Film

A

“Left shift” - Precursor cells present
Leukocytosis
Eosinophilia
Basophilia

Hypolobated megakaryocytes in bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CML - Diagnosis

A

Nearly all CML is associated with the Philadelphia chromosome

BCR-ABL1 fusion gene results from translocation of
t(9;22) and formation of the
Philadelphia chromosome

In exams they may use one of these three descriptions.
Detected by FISH currently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CML - Phases of Disease

A

Chronic (85-90%)

Accelerated - Increasing number of blasts in BM
Lack of response to therapy
Additional abnormalities in addition to BCR-ABL1

Blast phase -
>20% blasts in bone marrow
Behaves like an acute leukaemia

25
Q

CML - Rx

A

Tyrosine Kinase Inhibitors
1st Generation: Imatinib (mainstay of Rx)
2nd Generation: Dasatinib, Nilotinib, Bosutinib
3rd Generation: Ponatinib

> 90% 10 yr survival

Small percentage of patients will fail treatment and need transplants.

26
Q

CLL - Hx and Ex

A

Usually asymptomatic
Picked up on routine blood tests
Age >50 (median 65-70)– incidence increases with age
Twice as common in Men:Women
Can present with lymphadenopathy/splenomegaly
Can present with ITP (immune-mediated thrombocytopenic purpura) / Haemolytic anaemias

27
Q

CLL - Blood Tests

A

Normally – no anaemia at presentation
Anaemia at presentation = more aggressive disease or haemolytic anaemia present

Normally – no thrombocytopenia at presentation

High white cell count, often >100 x10^9

Normally – no neutropenia
Lymphocytosis - WCC is made up of mature lymphocytes

28
Q

CLL - Blood Film

A

Smear/smudge cells

Lymphocytosis

29
Q

CLL - Diagnosis

A

Aided by flow cytometry: - Identifying a “clonal” population of cells, Will express same cell markers e.g. Kappa/Lambda light chains.

Most frequently B-cells but can get T-cell CLL

Same pathology as Small Lymphocytic Lymphoma but different distribution of disease - CLL primarily in BM, SCC primarily in LNs

30
Q

CLL - Staging/Rx

A

Binet Staging

A – no cytopenia, <3 areas of lymphoid involvement
B – no cytopenia, 3+ areas of lymphoid involvement
C – cytopenias

A – watch and wait
B – consider treatment
C – treat

Richters syndrome: transformation of CLL to aggressive disease (ALL / high grade lymphoma)

31
Q

CLL - Rx

A

Options:
Ibrutinib (Brutons tyrosine kinase inhibitor)
FCR (fludarabine, cyclophosphamide, rituximab) – chemo regimen

Stem cell transplant

If p53 deletion - alemtuzumab

Watchful waiting/supportive treatment with transfusions/infection prophylaxis

32
Q

Lymphomas (Hodkins vs Non-Hodgkins) - Characteristics

A
HODKINS
Age: young
LN: mediastinum (anywhere), painful on drinking
Course: aggressive
Prognosis: mostly curable 
NON-HODGKINS
Age: increases with age
LNs: anywhere
Course: variable 
Prognosis: variable
33
Q

Lymphomas - Classification

A
There are ~60 types of lymphoma 
Broadly classified into:
Hodgkins vs Non-Hodgkins
B-cell vs T-cell
Very high vs High vs Low grade

Hodgkins - 4 types

Non-Hodgkins:
T-Cell - ATLL (adult T-cell leukaemia/lymphoma)
B-Cell - Burkitt’s, DLBCL (diffuse large B-cell lymphoma), mantle cell, follicular

34
Q

Lymphomas - Classification

A

Ann-Arbor Staging:
1- 1 set of LN involvement, 1 side of diaphragm
2 - multiple sets of LN involvement, 1 side of diaphragm
3 - LN involvement both sides of diaphragm
4 - bone marrow/splenic involvement

B Symptoms:
Fever >38 degrees
Drenching sweats at night
Unintentional weight loss >10% body weight in 6 months

35
Q

Hodgkin’s Lymphoma

A

Affects many young people (second peak in later life)
Presentation with lymphadenopathy or “B”-symptoms
Frequently mediastinal lymphadenopathy - painful on drinking alcohol
Reed-Sternburg cells are diagnostic (only 1 needed)

Nodular sclerosing is the most common type
Can be associated with EBV infection
Treatment is with ABVD chemotherapy usually + radiotherapy
Most patients have a good chance of cure
Stem cell transplants for rare cases who fail treatment

36
Q

Non-Hodgkin Lymphoma - General

A

Many sub-types – mostly B-cell origin, can be T-cell.
Present with B-symptoms or lymphadenopathy
Incidence increases with age
May be indolent or high-grade

37
Q

Non-Hodgkin Lymphoma - Indolent

A

Most common “indolent” lymphoma is Follicular Lymphoma
Small lymphocytic lymphoma is similar to CLL but with disease in nodes
Present with lymphadenopathy – usually few very large nodes
Risk of transformation to high grade lymphoma

38
Q

Follicular Lymphoma

A
  • Large numbers of centroblasts on lymph node biopsy
  • t(14;18) causes fusion of BCL2 gene
  • Treatment is watchful waiting unless high burden of disease.
39
Q

Non-Hodgkin Lymphoma - High-Grade

A

Most common “high grade” lymphoma is Diffuse Large B-Cell Lymphoma

Present with lymphadenopathy & frequently B-symptoms

May have Bone Marrow involvement

Risk of Tumour Lysis Syndrome with treatment

40
Q

Mantle Cell Lymphoma

A
  • t(11;14) causes overexpression of Cyclin D1
  • Treatment is with chemotherapy
  • May have “leukaemic phase”
  • Film will show “mantle cells” - cleft in the nucleus
41
Q

Diffuse Large B-Cell Lymphoma

A
  • Treatment is with Rituximab-CHOP chemotherapy

- Can be associated with EBV

42
Q

Burkitt’s Lymphoma

A

Some lymphomas are very fast growing.
Commonest example is Burkitt’s Lymphoma.
High risk of Tumour Lysis Syndrome with treatment.

  • “Starry sky” appearance on histology
  • Mostly associated with t(8;14)
  • Associated with EBV + HIV
  • Large fast growing lymph nodes in neck / elsewhere
43
Q

Adult T-Cell Leukaemia/Lymphoma (ATLL)

A

T-cell lymphomas are less common
ATLL is one example
Cutaneous T-cell lymphomas are rare and present with weird rashes

  • More common in far east
  • Associated with HTLV-1
  • “flower cells” on blood film
44
Q

Multiple Myeloma - Definition

A

“Plasma cell dyscrasia”

Clonal population of plasma cells which proliferate and produce monoclonal immunoglobulin light chains
Blood - paraprotein
Urine - Bence Jones Protein

45
Q

Myeloma Progression - Myeloma

A

Myeloma:
Clonal bone marrow plasma cells >10% in the marrow or plasmacytoma

And end organ damage

1 or more:
Calcium: Hypercalcaemia >2.75 
Renal: Creatinine clearance <40ml/min / Creatinine >177
Anaemia Hb <100g/l
Bone lesions – lytic lesions
46
Q

Myeloma Progression - Smouldering Myeloma/Aymptomatic Myeloma

A

Serum monoclonal protein (IgG / IgA) >30g/l or Bence Jones Protein
And/or
Clonal bone marrow plasma cells 10%-60% in the marrow

No end organ damage

Most will progress to myeloma untreated

47
Q

Myeloma Progression - Monoclonal Gammopathy of Unknown Significance

A

Serum monoclonal protein <30g/l
Plasma cells <10% on Bone Marrow

No end organ damage
No evidence of other disorder

1-2% per year progress to myeloma

48
Q

Waldenstrom’s Macroglobulinaemia

A

Similar to multiple myeloma but rare.

  • The paraprotein is always IgM (you can also get IgM Myeloma)
  • They present with lymphadenopathy and similar to follicular lymphoma
  • There is an abnormality in the lymphoplasmatoid cells as well as plasma cells
  • They are at risk of hyperviscosity syndrome
49
Q

Myeloma - Diagnosis

A

Blood film - Plasma cells (look a bit like fried eggs), rouleaux formation

50
Q

Myeloma - Rx

A

MGUS: annual blood test
Smouldering myeloma / Myeloma – treat in most cases

Rx is changing every year.

PRINCIPLES
Younger patients: chemotherapy then autologous stem cell transplant
Older patients: chemotherapy then maintenance therapy

Commonly used drugs in initial treatment:
Velcade (bortezomib) 
Revlimid (lenalidomide)
Dexamethasone
Cyclophosphamide

Subsequent treatments:
Pomalidomide
Daratumumab
Melphalan

51
Q

Haematopoietic Stem Cell Transplant

A

Autologous or Allogeneic

Principles:
Stem cells harvested from bone marrow / blood
Recipient receives chemotherapy to destroy their marrow
Stem cells infused into recipient

Approximately 10% die in the first year

Long-term SEs include: cataracts, thyroid problems, lung damage, infection, infertility, skin rashes, weakened bones

52
Q

Myelodysplastic Syndromes - General

A
Dysplastic changes (abnormal cells) 
1 or more myeloid cell lines (erythroid, megakaryocyte, granulocyte)

Usually asymptomatic, but risk of progression to AML
Present with incidental cytopenia

Around 30% would progress to AML. Risk is assessed using IPSS score.

53
Q

Myelodysplastic Syndromes - Anaemia

A

Anaemia with normal ferritin (iron), B12, Folate and erythropoitin levels raises suspicion of MDS
Usually this is macrocytic anaemia

54
Q

MDS with Ring Sideroblasts

A

> 15% ring sideroblasts
Anaemia
Or multilineage dysplasia

55
Q

MDS with Multilineage Dysplasia

A

2-3 cell lineages affected

<5% blasts

56
Q

MDS with Excess Blasts

A

> 5% blasts
10-19% blasts = “MDS with excess blasts 2)
20% blasts = AML

57
Q

MDS with Isolated del(5q)

A

Del(5q) is a separate but related syndrome

Anaemia
Normal / high platelets
<5% blasts

58
Q

MDS - Rx

A

Supportive - transfusions, EPO, G-CSF, ABX

Biological modifiers - immunosuppressive drugs, lenalidomide, azacytidine

(Think don’t worry too much about this - Jack PP says beyond scope of 5th year)

59
Q

MDS - Prognosis

A

Depends on International Prognostic Scoring System (IPSS): BM blast %; karyotype; degree of cytopenia

Mortality rule of 1/3: 1/3 die from infection, 1/3 die from bleeding, 1/3 die from acute leukaemia